KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Taxes (2019 - 2025)

Ionis Pharmaceuticals has reported Change in Taxes over the past 7 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Change in Taxes at $2.6 million for Q4 2025, up 37414.29% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (up 226.55% YoY), and the annual figure for FY2025 was $2.7 million, up 226.55%.
  • Change in Taxes for Q4 2025 was $2.6 million at Ionis Pharmaceuticals, up from $20000.0 in the prior quarter.
  • Over the last five years, Change in Taxes for IONS hit a ceiling of $26.0 million in Q2 2025 and a floor of -$28.9 million in Q4 2023.
  • Median Change in Taxes over the past 5 years was $11000.0 (2021), compared with a mean of $119850.0.
  • Peak annual rise in Change in Taxes hit 316800.0% in 2023, while the deepest fall reached 563.97% in 2023.
  • Ionis Pharmaceuticals' Change in Taxes stood at -$414000.0 in 2021, then surged by 1605.56% to $6.2 million in 2022, then plummeted by 563.97% to -$28.9 million in 2023, then surged by 99.98% to -$7000.0 in 2024, then surged by 37414.29% to $2.6 million in 2025.
  • The last three reported values for Change in Taxes were $2.6 million (Q4 2025), $20000.0 (Q3 2025), and $26.0 million (Q2 2025) per Business Quant data.